Registrations are Open, please visit https://www.vu.edu.pk/apply/

Benefits:

Completing this course will earn you:

• A FREE VU Course Participation Certificate

• A VU Course Completion Certificate *

• AI concept building with Real-life examples

Eligibility Criteria:

• Intermediate or equivalent

Classes Starting Date:

• December 21, 2020

For more information, please write to: mimran@vu.edu.pk

• Terms & Conditions Apply

Many of these have gone to hospitals, where the XR-1 provides information to patients and helps guide visitors to the proper department.

The artificial intelligence (AI) incorporated into the machines means they will operate their own. They are also connected to the newest 5G mobile networks, which suggests they will react very quickly.

“The fast speeds and wide reach of 5G networks make them ideal for XR-1, which interacts by talking, gesturing, dancing and physically guiding people,” says CloudMinds president Karl Zhao.

According to Wuhan Wuchang military hospital dean Wan Jun, they need been helpful. “CloudMinds robots’ contactless operation and reliability supported the sector hospital through a difficult time,” he says.

A few dozen robots isn’t getting to make an enormous dent within the coronavirus outbreak, but it might be a symbol of what is coming.

Artificial intelligence has made big progress in tasks like processing speech, which is making digital helpers more and more useful.

Dr Anita Montes, an obstetrician-gynaecologist based in North Carolina, says voice-enabled app Suki saves her “hours and hours a day” writing notes.
Image copyright Anita Montes
Image caption Dr Montes uses a digital assistant to require notes

“Proper charting is significant to good patient care,” she says.

She thinks the service could be helpful for doctors who are handling Covid-19 patients as a result: “They might be spending 12 hours seeing patients, then hours more charting them, so any tools which will cut the time it takes are really helpful.”

Until now, most people’s experience of digital assistants has been limited to recreationally focused services like Amazon’s Alexa and Apple’s Siri.

“Business usage is growing, but the digital assistant market is usually residential at the instant ,” says Blake Kozak, an analyst at global technology researcher Omdia.

But quarantined helpers are turning to AI tools for help.

“We are currently fixing more meetings than we ever have before,” says Dennis Mortensen, chief executive and co-founder of x.ai, an AI meeting scheduling tool that emails participants with potential times.

“The situation is making people address software solutions, and that i doubt they’re going to return once things return to normal.”

That’s excellent news for Microsoft, which recently began removing consumer-facing features like controlling music from its assistant Cortana’s skill set, and concentrating on personal productivity applications like reading emails aloud and scheduling meetings.
Image copyright Getty Images
Image caption Microsoft wants Cortana to be a private productivity tool

“There may be a need for an assistant which will transcend answering questions or setting alarms,” Microsoft said during a statement.

“Our ultimate goal for Cortana is to make an assistant which will assist you revisit time through your day so you’ll specialise in the items that matter most.”

However, for anyone keen to use a digital assistant to lighten their load, Mr Mortensen advises choosing a variety of tools that every do one thing well.

“I don’t expect anybody digital assistant to be ready to do everything, but I do think we’ll see start to ascertain AI agents being employed to try to to very well-defined tasks within subsequent five years,” he says.

“You might need 10 or 11 to try to to all the small jobs you would like doing, but if we will get all of them to speak to every other, they might do truly great things.”

More Technology of Business

the key chemical cocktails behind coronavirus testing
Computer games: quite a lockdown distraction
Coronavirus threatens subsequent generation of smartphones
‘The phone slipped into the bath’: call tales
The robots helping to fight coronavirus

The staff at New York-based AI specialist IPsoft hope that’s the case.

It develops software packages designed to fulfil roles traditionally performed by people, like an IT service desk engineer.

Via its new online marketplace, prospective employers can interview the company’s assistant Amelia to make a decision if they ought to combat a digital employee instead of an individual .

Costing $1,800 (£1,460) a month, their IT troubleshooter can reset passwords, unlock accounts and affect up to 1,000 inquiries a month.

So should humans be worried about these up-and-coming digital rivals?

Not consistent with Chloe Jessamy of admin support and digital marketing company Supportal Business Services in London.
Image copyright Chloe Jessamy, Supportal Business Services
Image caption Chloe Jessamy isn’t concerned about the challenge from digital assistants

Her company supplies services, including PAs and web design, performed by humans, not computers.

“I am not in the least worried about digital assistants,” she says.

“My clients want hands-on support and communication, which needs a person’s touch. There’s only such a lot automation you’ll use.”

Dr Will Venters, professor of data systems at the London School of Economics, supports this view.

“Bots need careful management,” he says

"They won’t question their work, they hold no ethical compass, they can’t easily explain how they received a choice and that they cannot understand the biases they could be applying.

“Further, they work so quickly that the issues they cause can rapidly scale out of control.”

So having a digital helper might cause you to more productive, but it’s worth remembering that they’re not perfect.

Perhaps Artificial Intelligence is a bit overstated. But when it comes to medicine, there is a proven record of how useful artificial intelligence has been in this field.

So can artificial intelligence help with the challenge of discovering the cure for this dangerous disease?

Many companies are in the race to solve this problem.

Accenta, a company based in Oxford, which first tested humans with artificial intelligence, is busy researching 15,000 drugs at the Scripps Research Institute in California.

Helix, a Cambridge company founded by Viagra co-creator Dr. David Brown, has turned the artificial intelligence system to finding medicines for uncommon ailments. Now their goal is to discover Corona’s treatment.

The system is divided into three parts:

• Review all current literature literature

• To study the DNA’s DNA structure and structure

• Evaluate the fit of different medicines

The drug discovery process has traditionally been quite slow.

Dr. Brown told BBC News, ‘I’ve been doing this for 45 years and so far I’ve only been able to bring three medicines to market.’

But artificial intelligence is proving very fast.

“It has taken us several weeks to gather the required data and we have also received new information in the last few days so we have a large amount of data,” says Dr. Brown.

“The algorithm was run on Easter and in the next seven days we will have the results of all three procedures,” he explains.

Helix hopes that in light of this information, he will make a list of possible drugs by May and he is discussing laboratories for his clinical trials.

When it comes to the Corona virus, there are two ways for those seeking treatment with artificial intelligence:

• Looking for a completely new drug but having to wait a few years to approve its safe use
• Rejuvenating existing medicines with a new purpose

But Dr. Brown said there was absolutely no possibility that the cure could be cured with a single drug.

For Helix, this means a detailed analysis of eight million potential pairs and 10.5 billion collections of medicines made possible with over 4,000 approved medicines in the market.

“Artificial intelligence is one of the strongest paths we have to achieve a viable drug,” Professor Ara Tarazi, director of the Institute of Global Health Innovation at Imperial College, told BBC News. But the basic requirement for this is a set of high quality, large and clear data. ’

“To date, much of this information has been sent to individual companies, such as large pharma companies or these have been lost in old laboratories within universities.”

“Now more than ever, there is a need to combine data sources involved in the discovery of these proportional materials, so that researchers of artificial intelligence are using their new machine learning techniques to discover the treatment of Cod-19 as soon as possible.” Can do. ’

Barabasi Laboratory of North Eastern University in the United States, Harvard Medical School, Stanford Network Science Institute and Biotech start-up Shaffer Madison, all looking for a drug that has been re-developed as a treatment for Cod-19. Can go

Amazing discovery

Alf Saleh, chief executive of Shaffer, said it would normally take ‘a year in the paperwork’ to work together.

“But with people who have the ability to make the work logical and have the time, a whole series of zoom calls can be made to speed up the process.”

He says’ the work done in the last three weeks usually takes half a year. Everyone has paid attention to everything else. ’

And the amazing results of their research are starting to emerge. Including:

• The suggestion that the virus may be invading brain cells, causing some people to lose a sense of taste or smell.

• It is predicted that the virus could also attack the reproductive system of both males and females

Shaffer Madison combines artificial intelligence with something they call Network Medicine. It is a method of visualizing a disease through a complex interaction between molecular components.

Saleh says, 'The disease that comes to us is rarely due to a single gene or protein defect. Nature is not so easy. Rather, it is the result of a clash between multiple proteins. ’

Consortium has identified 81 potential drugs that may be helpful, using Network Medicine, artificial intelligence and the fusion of both.

Professor Albert Laszlo Barabasi says, ‘Artificial intelligence can do a lot of good work, not only to improve the order, but also to look for free information that may not go beyond network medicine.’

But artificial intelligence can’t do it alone, it requires all three of these methods.

He adds, ‘Different tools see things from different perspectives, but together they become very powerful.’

Some artificial intelligence companies are already claiming that they have identified some drugs that may be helpful.

Benevolent artificial intelligence has identified ‘baristinib’ as a potential cure for the prevention of a virus affecting lung cells, leading to inflammation of the bones (which causes inflammation in the joints of water in the joints). Is a medicine approved for treatment.

And now controlled trials are being conducted at the US Institute for Allergy and Infectious Diseases.

Meanwhile, scientists from South Korea and the US have used Deep Learning to highlight their research using commercially available anti-viral drugs such as azinavir (a drug used to treat AIDS). Is.

Other companies are using artificial intelligence for other purposes, such as analyzing scans to reduce the burden on radiologists and helping predict which patients will need more ventilators.

For example, Chinese technology guru Alibaba announced an algorithm that can diagnose people infected with the virus within 20 seconds, with 96% accurate results.

But some experts warn that it is hardly possible that artificial intelligence systems have been trained on advanced disease statistics, and therefore may not be so effective at detecting early signs of the virus. Yes

Professor Darzi said that policy makers globally should try to convince large pharmaceutical companies, academics and research charities to work together using their data sources.

They say, ‘There could be no better chance to share data and discover the secrets of technology to help artificial intelligence in the fight against Cod-19.’